Development and evaluation of a multiplex molecular point-of-care assay for direct identification of Mycobacterium tuberculosis and prioritized non-tuberculous mycobacteria
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1560870 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Qiao-Lian Yi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beiji…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Nontuberculous Mycobacteria, Point-of-Care Systems, Tuberculosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aimed to establish a multiplex molecular point-of-care assay called fastNTM incorporating an ultra-fast sample pre-treatment for direct identification of Mycobacterium tuberculosis complex (MTBC) and 8 non-tuberculous Mycobacteria (NTM) commonly prioritized in clinical settings, and to evaluate its performance in 149 clinical confirmed mycobacterial-positive samples.
Methods
The study was divided into two stages: a pilot study to establish the methodology and a clinical validation study to evaluate its performance. In the pilot study, we established the fastNTM and analyzed its performance regarding limits of detection, reproducibility, specificity and efficiency. The clinical validation study was performed using 149 clinical confirmed mycobacterial-positive samples, with 16S rRNA identification as the reference standard. The complete process, from patient to result, was accomplished within 90 minutes.
Results
Of the 149 positive clinical mycobacterial cultures analyzed, 136 were within the designed targets. Among these 136 cultures, 133 samples were correctly identified by fastNTM , achieving an accuracy rate of 97.79%.
Conclusions
This study demonstrates that fastNTM with its high accuracy rate are capable to rapidly and effectively differentiate between MTBC and the major NTM species.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Graduate School, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- R&D Department Genewise Bio Co., Ltd, Beijing, China.
- State Key Laboratory of Complex, Severe, and Rare Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zitieren
APA
Yi, Q. L., Wu, Y., He, S., Feng, M. L., Liu, X. Y., Zhou, X. Z., Gao, H. T., Zhang, Y. F., Yang, Q. W., & Xu, Y. C. (2025). Development and evaluation of a multiplex molecular point-of-care assay for direct identification of Mycobacterium tuberculosis and prioritized non-tuberculous mycobacteria. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1560870
Vancouver
Yi QL, Wu Y, He S, Feng ML, Liu XY, Zhou XZ, et al. Development and evaluation of a multiplex molecular point-of-care assay for direct identification of Mycobacterium tuberculosis and prioritized non-tuberculous mycobacteria. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1560870
BibTeX
@article{Yi2025,
author = {Yi, Qiao-Lian and Wu, Yun and He, Shuang and Feng, Meng-Li and Liu, Xiao-Yu and Zhou, Xin-Zhu and Gao, Hao-Tian and Zhang, Yu-Fan and Yang, Qi-Wen and Xu, Ying-Chun},
title = {Development and evaluation of a multiplex molecular point-of-care assay for direct identification of Mycobacterium tuberculosis and prioritized non-tuberculous mycobacteria},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1560870}
}
EUVIMED